［1］ Liu PP,Mason JW.Advance in the understanding of myocarditis ［J］.Circulation,2001,104(9):1076-1082.［2］ Richardson P,Mckenna W,Bristow M, et al.Report of the 1995 World Health Organization /International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies［J］.Circulation,1996,93(5):841-842.
［3］ Zorc M,Vraspir Porenta O,Zorc Pleskovic R, et al.Apoptosis of myocytes and proliferation markers as prognostic factors in end stage dilated cardiomyopathy［J］. Cardiovasc Pathol，2003,12(1):36-39.
［4］ Kubota T,Miyagishima M,Frye CS,et al.Overexpression of tumor necrosis factorα activates both antiand pro apoptotic pathways in the myocardium［J］.J Mol Cell Cardiol,2001,33(7):1331-1344.
［5］ Sun M,Chen M,Dawood F,Zurawska U,et al.Tumor necrosis factor alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state［J］.Circulation ,2007,115(11):1398-1407.
［6］ Li X,Yang Y,Ashwell JD.TNF RⅡ and c-IAP1 mediate ubiqutination and degradation of TRAF2［J］.Nature,2002,416:345-349.
［7］ Chan FK,Lenardo MJ.A crucial role for p80 TNF R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes［J］. Eur J Immunol, 2000,30:652-660.
［8］ Weinshenker BG,Hebrink D,Wingerchuk DM,et al.Genetic variants〖JP〗 in the tumor necrosis factor receptor 1 gene in patients with MS［J］.Neurology,1999,52(7):1500-1503.
［9］ Komata T,Tsuchiya N,Matsushita M,et al.Association of tumor necrosis factor receptor 2(TNFR2) polymorphism with susceptibility〖JP〗 to systemic lupus erythematosus［J］.Tissue Antigens,1999,53(6):527-533.
［10］ Kim JY,Moon SM,Ryu HJ,et al.Identification of regulatory polymorphisms in the TNF receptor superfamily［J］.Immunogenetics,2005,57(5):297-303.
［11］ Aksentijevich I,Galon J,Soares M,et al.The tumour necrosis factor receptor associated periodic syndrome:new mutations in TNFRSF1A, ancestral origins,genotypephenotype studies,and evidence for further genetic heterogeneity of periodic fevers［J］. Am J Hum Genet, 2001,69(2):301-314.
［12］ Dahlqvist SR,Arlestig L,Sikstrom C, et al.Tumor necrosis factor receptor type II(exon 6) and interleukin6(174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from northern Sweden［J］.Arthritis Rheum, 2002,46(11):3096-3098.
［13］ John RG,Peter TD,Nicola BN,et al. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis［J］.J Arthritis Research & Therapy, 2005,7(6):1227-1234.
［14］ Till A,Rosenstiel P,KrippnerHeidenreich A, et al.The met196→Arg variation of hunman tumor necrosis factor receptor 2(TNFR2) affects TNFalphainduced apoptosis by impaired NFkappaB signaling and target gene expression［J］.J Biol Chem ,2005,280(7):5994-6004.